Cancer

A transformative study has provided a profound understanding of glioblastoma's molecular subtypes, revealing the nuances of cellular heterogeneity and the...

Demystifying APE1: New findings on direct activation of ATM signaling by DNA single-strand breaks

New research from a team of genome scientists and DNA damage response experts breaks new ground in understanding the function...

FDA approves drug targeting Johns Hopkins-discovered brain cancer gene mutation

FOR IMMEDIATE RELEASECredit: Elizabeth Cook FOR IMMEDIATE RELEASE A new drug for treatment of a type of brain cancer, called...

FDA approves new therapy for glioma patients for first time in decades

Boston – Vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for patients with Grade 2 gliomas...

How does an effective cancer therapy damage the heart?

Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a protein receptor on T immune cells that prevents the cells from killing other...

Gestational diabetes does not increase risk of breast cancer, large Danish study finds

*Note this is an early release from the Annual Meeting of the European Association of the Study of Diabetes (EASD...

Drug bypasses suppressive immune cells to unleash immunotherapy

By recruiting the immune system to combat tumor cells, immunotherapy has improved survival rates, offering hope to millions of cancer...

Better cancer trial representation begins with speaking one’s language

NEW YORK, NY (July 29, 2024) ---- Underrepresentation of racial and ethnic minority populations in cancer clinical trials persists partly...

Research spotlight: Identifying potential new protein targets for melanoma therapeutics

How would you summarize your study for a lay audience? How would you summarize your study for a lay audience?...

Damon Runyon Cancer Research Foundation awards $5.2 million to top clinical investigators